Silencing of human α-synuclein in vitro and in rat brain using lentiviral-mediated RNAi

Experimental Neurology

Volumn 198, Issue 2, 2006, Pages 382-390

  Sapru, Mohan K ^a   Yates, Jonathan W ^a   Hogan, Shea ^a   Jiang, Lixin ^a   Halter, Jeremy ^a   Bohn, Martha C ^a  

^a CHILDREN S MEMORIAL RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; ENHANCED GREEN FLUORESCENT PROTEIN; LENTIVIRUS VECTOR; PLASMID VECTOR; SHORT HAIRPIN RNA; SMALL INTERFERING RNA;

ALLELE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL STRAIN; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; GENE IDENTIFICATION; GENE SILENCING; GENETIC CODE; IN VITRO STUDY; IN VIVO STUDY; MALE; MARKER GENE; NERVE CELL CULTURE; NONHUMAN; NUCLEOTIDE SEQUENCE; PARKINSON DISEASE; POSTTRANSCRIPTIONAL GENE SILENCING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; RAT; RNA INTERFERENCE; VIRAL GENE DELIVERY SYSTEM;

ALLELES; ALPHA-SYNUCLEIN; ANIMALS; BRAIN; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION; GREEN FLUORESCENT PROTEINS; HELA CELLS; HUMANS; LENTIVIRUS; MALE; MUTANT PROTEINS; PHOSPHOPYRUVATE HYDRATASE; RATS; RATS, WISTAR; RNA INTERFERENCE; RNA, SMALL INTERFERING; TRANSFECTION;

EID: 33645854350     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2005.12.024     Document Type: Article

References (47)

1. Abbas-Terki T., Blanco-Bose W., Deglon N., Pralong W., and Aebischer P. Lentiviral-mediated RNA interference. Hum. Gene Ther. 13 (2002) 2197-2201
2. Abdelgany A., Wood M., and Beeson D. Allele-specific silencing of a pathogenic mutant acetylcholine receptor subunit by RNA interference. Hum. Mol. Genet. 12 (2003) 2637-2644
3. Baer M., Nilsen T.W., Costigan C., and Altman S. Structure and transcription of a human gene for h1 rna, the RNA component of human RNase P. Nucleic Acids Res. 18 (1990) 97-103
4. Betarbet R., Sherer T.B., MacKenzie G., Garcia-Osuna M., Panov A.V., and Greenamyre J.T. Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nat. Neurosci. 3 (2000) 1301-1306
5. Brummelkamp T.R., Bernards R., and Agami R. A system for stable expression of short interfering RNAs in mammalian cells. Science 296 (2002) 550-553
6. Chartier-Harlin M.C., Kachergus J., Roumier C., Mouroux V., Douay X., Lincoln S., Levecque C., Larvor L., Andrieux J., Hulihan M., Waucquier N., Defebvre L., Amouyel P., Farrer M., and Destee A. Alpha-synuclein locus duplication as a cause of familial Parkinson's disease. Lancet 364 (2004) 1167-1169
7. Connor B., Kozlowski D.A., Schallert T., Tillerson J.L., Davidson B.L., and Bohn M.C. Differential effects of glial cell line-derived neurotrophic factor (GDNF) in the striatum and substantia nigra of the aged Parkinsonian rat. Gene Ther. 6 (1999) 1936-1951
8. Elbashir S.M., Harborth J., Lendeckel W., Yalcin A., Weber K., and Tuschl T. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411 (2001) 494-498
9. Elbashir S.M., Martinez J., Patkaniowska A., Lendeckel W., and Tuschl T. Functional anatomy of siRNAs for mediating efficient RNAi in Drosophila melanogaster embryo lysate. EMBO J. 20 (2001) 6877-6888
10. Escarpe P., Zayek N., Chin P., Borellini F., Veres R., and Kiermer G. Development of a sensitive assay for detection of replication-competent recombinant lentivirus in large-scale HIV-based vector preparations. Mol. Ther. 8 (2003) 331-341
11. Farrer M., Maraganore D.M., Lockhart P., Singleton A., Lesnick T.G., de Andrade M., West A., de Silva R., Hardy J., and Hernandez D. Alpha-synuclein gene haplotypes are associated with Parkinson's disease. Hum. Mol. Genet. 10 (2001) 1847-1851
12. Feany M.B., and Bender W.W. A Drosophila model of Parkinson's disease. Nature 404 (2000) 394-398
13. Fernagut P.O., and Chesselet M.F. Alpha-synuclein and transgenic mouse models. Neurobiol. Dis. 17 (2004) 123-130
14. Fire A., Xu S., Montgomery M.K., Kostas S.A., Driver S.E., and Mello C.C. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391 (1998) 806-811
15. Follenzi A., Sabatino G., Lombardo A., Boccaccio C., and Naldini L. Efficient gene delivery and targeted expression to hepatocytes in vivo by improved lentiviral vectors. Hum. Gene Ther. 13 (2002) 243-260
16. Fornai F., Schluter O.M., Lenzi P., Gesi M., Ruffoli R., Ferrucci M., Lazzeri G., Busceti C.L., Pontarelli F., Battaglia G., Pellegrini A., Nicoletti F., Ruggieri S., Paparelli A., and Sudhof T.C. Parkinson-like syndrome induced by continuous MPTP infusion: convergent roles of the ubiquitin-proteasome system and {alpha}-synuclein. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 3413-3418
17. Gomez-Santos C., Ferrer I., Reiriz J., Vinals F., Barrachina M., and Ambrosio S. MPP+ increases alpha-synuclein expression and ERK/MAP-kinase phosphorylation in human neuroblastoma SH-SY5Y cells. Brain Res. 935 (2002) 32-39
18. Gonzalez-Alegre P., Miller V.M., Davidson B.L., and Paulson H.L. Toward therapy for DYT1 dystonia: allele-specific silencing of mutant TorsinA. Ann. Neurol. 53 (2003) 781-787
19. Hannon G.J. RNA interference. Nature 418 (2002) 244-251
20. Iwai A., Masliah E., Yoshimoto M., Ge N., Flanagan L., de Silva H.A., Kittel A., and Saitoh T. The precursor protein of non-A beta component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system. Neuron 14 (1995) 467-475
21. Jellinger K.A. Lewy body-related alpha-synucleinopathy in the aged human brain. J. Neural Transm. 111 (2004) 1219-1235
22. Karolewski B.A., Watson D.J., Parente M.K., and Wolfe J.H. Comparison of transfection conditions for a lentivirus vector produced in large volumes. Hum. Gene Ther. 14 (2003) 1287-1296
23. Kirik D., Annett L.E., Burger C., Muzyczka N., Mandel R.J., and Bjorklund A. Nigrostriatal alpha-synucleinopathy induced by viral vector-mediated overexpression of human alpha-synuclein: a new primate model of Parkinson's disease. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 2884-2889
24. Kruger R., Kuhn W., Muller T., Woitalla D., Graeber M., Kosel S., Przuntek H., Epplen J.T., Schols L., and Riess O. Ala30pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. Nat. Genet. 18 (1998) 106-108
25. Lauwers E., Debyser Z., Van Dorpe J., De Strooper B., Nuttin B., and Baekelandt V. Neuropathology and neurodegeneration in rodent brain induced by lentiviral vector-mediated overexpression of alpha-synuclein. Brain Pathol. 13 (2003) 364-372
26. Lo Bianco C., Ridet J.L., Schneider B.L., Deglon N., and Aebischer P. Alpha-synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson's disease. Proc. Natl. Acad. Sci. U. S. A. 16 (2002) 10813-10818
27. Marti M.J., Tolosa E., and Campdelacreu J. Clinical overview of the synucleinopathies. Mov. Disord. 18 Suppl. 6 (2003) S21-S27
28. Masliah E., Rockenstein E., Veinbergs I., Mallory M., Hashimoto M., Takeda A., Sagara Y., Sisk A., and Mucke L. Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders. Science 287 (2000) 1265-1269
29. McManus M.T., and Sharp P.A. Gene silencing in mammals by small interfering RNAs. Nat. Rev., Genet. 3 (2002) 737-747
30. Miller V.M., Xia H., Marrs G.L., Gouvion C.M., Lee G., Davidson B.L., and Paulson H.L. Allele-specific silencing of dominant disease genes. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 7195-7200
31. Neumann M., Muller V., Kretzschmar H.A., Haass C., and Kahle P.J. Regional distribution of proteinase K-resistant alpha-synuclein correlates with Lewy body disease stage. J. Neuropathol. Exp. Neurol. 63 (2004) 1225-1235
32. Pals P., Lincoln S., Manning J., Heckman M., Skipper L., Hulihan M., Van den Broeck M., De Pooter T., Cras P., Crook J., Van Broeckhoven C., and Farrer M.J. Alpha-synuclein promoter confers susceptibility to Parkinson's disease. Ann. Neurol. 56 (2004) 591-595
33. Polymeropoulos M.H., Lavedan C., Leroy E., Ide S.E., Dehejia A., Dutra A., Pike B., Root H., Rubenstein J., Boyer R., Stenroos E.S., Chandrasekharappa S., Athanassiadou A., Papapetropoulos T., Johnson W.G., Lazzarini A.M., Duvoisin R.C., Di Iorio G., Golbe L.I., and Nussbaum R.L. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 276 (1997) 2045-2047
34. Raghavan R., Kruijff L., Sterrenburg M.D., Rogers B.B., Hladik C.L., and White C.L. Alpha-synuclein expression in the developing human brain. Pediatr. Dev. Pathol. 7 (2004) 506-516
35. Richfield E.K., Thiruchelvam M.J., Cory-Slechta D.A., Wuertzer C., Gainetdinov R.R., Caron M.G., Di Monte D.A., and Federoff H.J. Behavioral and neurochemical effects of wild-type and mutated human alpha-synuclein in transgenic mice. Exp. Neurol. 175 (2002) 35-48
36. Rubinson D.A., Dillon C.P., Kwiatkowski A.V., Sievers C., Yang L., Kopinja J., Rooney D.L., Ihrig M.M., McManus M.T., Gertler F.B., Scott M.L., and Van Parijs L. A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference. Nat. Genet. 33 (2003) 401-406
37. Semizarov D., Frost L., Sarthy A., Kroeger P., Halbert D.N., and Fesik S.W. Specificity of short interfering RNA determined through gene expression signatures. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 6347-6352
38. Singleton A.B., Farrer M., Johnson J., Singleton A., Hague S., Kachergus J., Hulihan M., Peuralinna T., Dutra A., Nussbaum R., Lincoln S., Crawley A., Hanson M., Maraganore D., Adler C., Cookson M.R., Muenter M., Baptista M., Miller D., Blancato J., Hardy J., and Gwinn-Hardy K. Alpha-synuclein locus triplication causes Parkinson's disease. Science 302 (2003) 841
39. Song E., Lee S.K., Wang J., Ince N., Ouyang N., Min J., Chen J., Shankar P., and Lieberman J. RNA interference targeting Fas protects mice from fulminant hepatitis. Nat. Med. 9 (2003) 347-351
40. Spillantini M.G., Crowther R.A., Jakes R., Hasegawa M., and Goedert M. Alpha-synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with Lewy bodies. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 6469-6473
41. Tiscornia G., Singer O., Ikawa M., and Verma I.M. A general method for gene knockdown in mice by using lentiviral vectors expressing small interfering RNA. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 1844-1848
42. Tomar R.S., Matta H., and Chaudhary P.M. Use of adeno-associated viral vector for delivery of small interfering RNA. Oncogene 22 (2003) 5712-5715
43. Vila M., Vukosavic S., Jackson-Lewis V., Neystat M., Jakowec M., and Przedborski S. Alpha-synuclein up-regulation in substantia nigra dopaminergic neurons following administration of the Parkinsonian toxin MPTP. J. Neurochem. 74 (2000) 721-729
44. Watabe M., and Nakaki T. Rotenone induces apoptosis via activation of bad in human dopaminergic SH-SY5Y cells. J. Pharmacol. Exp. Ther. 311 (2004) 948-953
45. Xia H., Mao Q., Paulson H.L., and Davidson B.L. siRNA-mediated gene silencing in vitro and in vivo. Nat. Biotechnol. 20 (2002) 1006-1010
46. Xia H., Mao Q., Eliason S.L., Harper S.Q., Martins I.H., Orr H.T., Paulson H.L., Yang L., Kotin R.M., and Davidson B.L. RNAi suppresses polyglutamine-induced neurodegeneration in a model of spinocerebellar ataxia. Nat. Med. 10 (2004) 816-820
47. Zufferey R. Production of lentiviral vectors. Curr. Top. Microbiol. Immunol. 261 (2002) 107-121